Edition:
India

People: Adial Pharmaceuticals Inc (ADIL.OQ)

ADIL.OQ on NASDAQ Stock Exchange Capital Market

1.31USD
22 Sep 2020
Change (% chg)

-- (--)
Prev Close
$1.31
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
118,919
52-wk High
$3.16
52-wk Low
$1.00

Truluck, Joseph 

Mr. Joseph Truluck serves as Chief Financial Officer, Chief Operating Officer, Treasurer, Secretary of the Company. Mr. Truluck has served as the VP Operations and Finance at Adenosine Therapeutics, LLC after the company reacquired its major drug development program. As VP Operations and Finance, at Adenosine Therapeutics, Mr. Truluck has overseen the operations of the business, including seeing to completion a project to merge and analyze two partially completed Phase 3 trials to constitute a single trial. From April 2005 to July 2009, Mr. Truluck served as the Operations Manager of Adenosine Therapeutics’ until its purchase in August 2008 by Clinical Data. After the purchase of Adenosine Therapeutics’ operations by Clinical Data, Mr. Truluck went on to gain an MBA from Tulane University with a concentration in Finance. In addition to his MBA at Tulane, Mr. Truluck earned an MA in Philosophy at the University of Virginia, with a thesis in the area of modal semantics.

Basic Compensation

Total Annual Compensation, USD 144,931
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 582,143
Fiscal Year Total, USD 727,074

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --